---
category: news
title: "The AI Factor: Why Cash Still Flows To European Biotech Startups"
excerpt: "Despite concerns about startup investment overall, Biotech continues to attract VC capital. The combination of AI and biology is accelerating new treatment development"
publishedDateTime: 2023-11-24T19:02:00Z
originalUrl: "https://www.forbes.com/sites/trevorclawson/2023/11/24/the-ai-factor-why-cash-still-flows-to-european-biotech-startups/"
webUrl: "https://www.forbes.com/sites/trevorclawson/2023/11/24/the-ai-factor-why-cash-still-flows-to-european-biotech-startups/"
type: article
quality: 47
heat: 47
published: false

provider:
  name: Forbes
  domain: forbes.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/forbes.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI

secured: "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;39taxHCcmFZbavpqU/nPYw=="
---

